InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-23 · accession 0001225208-24-002951 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-26 2024-02-23 BSX Carruthers Wendy EVP, Human Resources M - OptEx $19.31 +4,263 62.3K +7% +$82.3K
D 2024-02-26 2024-02-23 BSX Carruthers Wendy EVP, Human Resources S - Sale+OE $66.89 -6,983 56.5K -11% -$467.1K
DM 2024-02-26 2024-02-23 BSX Carruthers Wendy EVP, Human Resources M - OptEx $0.00 -4,263 25.2K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-23 M A 1,197 $24.55 63,491 D — —
2 Common Common Stock 2024-02-23 S D 6,983 $66.89 56,508 D — —
3 Common Common Stock 2024-02-23 M A 3,066 $17.26 62,294 D — —
4 Derivative Stock Option (Right to Buy) 2024-02-23 M D 3,066 $0.00 30,660 D $17.26 · — to 2026-02-22 3,066 Common Stock (F2) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
5 Derivative Stock Option (Right to Buy) 2024-02-23 M D 1,197 $0.00 25,153 D $24.55 · — to 2027-02-28 1,197 Common Stock (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.